| Active substance |
Digoxin |
| Also known as |
Digitalis, Lanoxin |
| Blood pressure |
Can lower blood pressure via improved heart function |
| Chemical name |
3ОІ-[(O-2,6-dideoxy-ОІ-D-ribo-hexopyranosyl-(1в†’4)-O-2,6-dideoxy-ОІ-D-ribo-hexopyranosyl-(1в†’4)-2,6-dideoxy-ОІ-D-ribo-hexopyranosyl)oxy]-12ОІ,14-dihydroxy-5ОІ-card-20(22)-enolide |
| Dosage (medical) |
Typically 0.125 mg to 0.25 mg daily |
| Dosage (sports) |
Not applicable |
| Effects |
Increased cardiac output and improved heart efficiency |
| Formula |
C41H64O14 |
| Half-life |
36 to 48 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Plasma digoxin concentration measurement |
| Main action |
Increases the force of myocardial contraction |
| Side effects |
Nausea, dizziness, visual disturbances, and potentially serious cardiac arrhythmias |
| Storage conditions |
Store at room temperature, away from light and moisture |
| Strength |
0.25mg |
| Substance class |
Cardiac glycoside |
| Trade name |
Lanoxin |
| Use in sports |
Not typically used in sports due to its effects on heart rhythms and lack of performance enhancement |
| Water Retention |
No significant effect |
| Manufacturer |
GlaxoSmithKline |
| Packing |
10 tabs/blister |
